logo
  Join        Login             Stock Quote

Comments on The Nobel Prize Assembly's Response to the Lawsuit Filed by Life Scientist, Dr. Rongxiang Xu

Tuesday, March 5, 2013 12:40 PM


LOS ANGELES, March 5, 2013 /PRNewswire/ -- The Nobel Assembly at Karolinska Institutet, The Nobel Assembly responded to Dr. Rongxiang Xu's defamation lawsuit on Feb. 22, 2013 by filing a notice to remove the lawsuit from State Court to Federal Court, in Los Angeles.

(Photo: http://photos.prnewswire.com/prnh/20130305/LA71370)

According to attorneys for Dr. Xu, the transfer of the case to Federal Court would not affect the substantive nature of the lawsuit but is merely a procedural strategic move by the Defendant.  Dr. Xu's lawsuit was filed in December 2012 in connection with the Nobel Assembly's awarding of the 2012 Nobel Prize in Physiology or Medicine.

According to Dr. Xu, the lawsuit was not intended to tarnish the reputation of the Nobel Assembly, but it was filed, in part, to clarify a vital misunderstanding concerning the "conversion of human somatic cells into stem cells and regeneration of physiological tissues." Through his own research on human regenerative science during the past several decades, Dr. Xu claims to have discovered and proved that this conversion is an innate ability found in our cells, a natural phenomenon that he says he has demonstrated through successful clinical applications time and time again. According to his claims, the cellular conversion does not require the engineering of man-made cells, which is the approach that was taken by the recipients of the 2012 Nobel Prize.

In his complaint, Dr. Xu provides examples of the results of some of his clinical applications, including an array of patents and publications that detail and verify the "in situ conversion of human somatic cells into stem cells followed by in situ regeneration of physiological tissues." These applications include:

  • in situ skin regeneration for severe burns
  • regenerative restoration of severed fingers
  • regenerative elimination of cutaneous scars
  • in situ regeneration of degenerative atrophic gastrointestinal villi back to normal structure     of young status

Based on his results, Dr. Xu insists that the "conversion of human somatic cells into stem cells and regeneration of physiological tissues" is an innate human ability, not one that should be created by man-made cells. But since the Nobel Assembly awarded two scientists for the latter approach, for artificially converting somatic cells into a state of self-proclaimed "pluripotency" through nuclear transfer and cellular reprogramming, Dr. Xu believes that the Nobel Assembly had a duty to accurately describe the Laureates' works and acknowledge Dr. Xu's findings that were demonstrated and proved years earlier.  Dr. Xu believes that the Nobel Assembly's description of the Laureates' work was misleading and it disparaged and undermined his scientific achievements and professional reputation, which is what led to the filing of his complaint.

Dr.  Xu strongly believes that the public should be made aware of the critical distinction between having the "conversion of human somatic cells into stem cells and regeneration of physiological tissues" as an innate human ability versus one that is produced by artificial, man-made cells. The lawsuit is not only an action taken to protect his science, but also one that he hopes to edify the public about the responsibility in life science research regarding facticity of knowledge. After all, the Nobel Prize in Physiology or Medicine represents the mainstream of life science research and influences directly the safety of human lives, which is of the most importance.

About  Rongxiang Xu

Dr. Xu is the founder of human body regenerative restoration science. He filed a lawsuit in December 2012 against The Nobel Assembly at Karolinska Institutet, a body which awards the Nobel Prize in Physiology or Medicine. The suit was filed in Superior Court of the State of California, Orange County Central Justice Center and cites Libel and unfair competition. On October 8, 2012, The Nobel Prize in Physiology or Medicine 2012 was awarded jointly to Sir John B. Gurdon and Shinya Yamanaka "for the discovery that mature cells can be reprogrammed to become pluripotent. Dr. Xu alleges that some of the statements made by the Nobel Assembly were false as he was the scientist who made the discovery a decade earlier.

http://www.mebo-international.com/about-us/timeline

Please find an example of the regenerative restoration science below. For additional information contact:
Jane Westgate: 336-209-9276, Jane@westgatecom.com, or
Cheryl Riley: 703-683-1798, cherylrileypr@comcast.net.

SOURCE Mebo International

(Source: PR Newswire )
(Source: Quotemedia)

Advertisement
Advertisement



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.